Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
Detection, Assessment and Management of Pulmonary Fibrosis
Practical Melanoma Management for GPs
Preventing Renal Failure in Type 2 Diabetes – New Options
Management of Post-Vaccination Reactions
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis